TLOG (TetraLogic Pharmaceuticals) LT-Debt-to-Total-Asset: 0.72 (As of Sep. 2016)


What is TetraLogic Pharmaceuticals LT-Debt-to-Total-Asset?

TetraLogic Pharmaceuticals TLOG LT-Debt-to-Total-Asset is 0.72 as of Sep. 2016.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. TetraLogic Pharmaceuticals's long-term debt to total assests ratio for the quarter that ended in Sep. 2016 was 0.72.

TetraLogic Pharmaceuticals's long-term debt to total assets ratio increased from Sep. 2015 (0.31) to Sep. 2016 (0.72). It may suggest that TetraLogic Pharmaceuticals is progressively becoming more dependent on debt to grow their business.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

TetraLogic Pharmaceuticals LT-Debt-to-Total-Asset Related Terms

TetraLogic Pharmaceuticals LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals LT-Debt-to-Total-Asset Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
LT-Debt-to-Total-Asset
0.00 0.97 0.00 0.23 0.44

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.44 0.51 0.59 0.72

TetraLogic Pharmaceuticals LT-Debt-to-Total-Asset Calculation

TetraLogic Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2015 is calculated as

LT Debt to Total Assets (A: Dec. 2015 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2015 )/Total Assets (A: Dec. 2015 )
=28.279/64.021
=

TetraLogic Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2016 is calculated as

LT Debt to Total Assets (Q: Sep. 2016 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2016 )/Total Assets (Q: Sep. 2016 )
=30.809/42.788
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.72 mean?
TetraLogic Pharmaceuticals (TLOG) has a LT-Debt-to-Total-Asset of 0.72 as of Sep. 2016. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' LT-Debt-to-Total-Asset too high?
TetraLogic Pharmaceuticals' current LT-Debt-to-Total-Asset is 0.72.
How does TetraLogic Pharmaceuticals' LT-Debt-to-Total-Asset compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' LT-Debt-to-Total-Asset of 0.72 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current LT-Debt-to-Total-Asset is 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current LT-Debt-to-Total-Asset of 0.72. The current LT-Debt-to-Total-Asset is 0.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current LT-Debt-to-Total-Asset is 0.72 as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.